Donald Morel Jr Buys Shares of Stevanato Group

Donald Morel Jr, an insider at Stevanato Group S.p.A. (NYSE:STVN), purchased 4,975 shares of the company on June 12, 2026. The transaction did not disclose the purchase price. On Friday, Stevanato's stock traded near $18.39.

Insider Buying and Selling at Stevanato Group S.p.A.

Morel's purchase was part of a series of insider activities around the same period. On June 15, 2026, insiders including Karen Flynn, William Federici, and Madhavan Balachandran each sold 1,493 shares at an average price of $17.09. Marco Dal Lago, the Chief Financial Officer, also bought 2,356 shares on June 12, 2026, alongside Morel.

Other Institutional Activity in Stevanato Group

Several institutional investors also adjusted their holdings in Stevanato Group. Conestoga Capital Advisors, LLC increased its stake by 602,050 shares, bringing its total to 8,491,751 shares valued at approximately $116.76 million, a 7.6% increase. On the other hand, Neuberger Berman Group LLC reduced its position by 312,219 shares, holding 4,475,492 shares worth $61.54 million, a decrease of 6.5%. T. Rowe Price Investment Management, Inc. trimmed its holdings by 698,724 shares, now owning 3,224,908 shares valued at $44.34 million, marking a 17.8% decrease.

Stevanato Group S.p.A. Stock Down 12.6%

Shares of Stevanato Group traded near $18.39 on Friday. The company has a market capitalization of approximately $5.02 billion and a P/E ratio of 31.7. Its stock has seen a 52-week low of $12.89 and a high of $28.00. Stevanato Group's 50-day moving average is $17.39, while the 200-day moving average is $19.57. The company maintains a current ratio of 1.63 and a quick ratio of 1.11, with a debt-to-equity ratio of 29.43.

Recent Earnings

For its most recent quarter, Stevanato Group reported revenue of $1.20 billion, reflecting a growth of 6.6%. The net margin stood at 11.75%, and the return on equity was 9.59%. The company's earnings per share were $0.58. Stevanato Group is scheduled to announce its next earnings on May 7, 2026.

Dividend

Stevanato Group pays an annual dividend rate of $0.06, yielding 0.34% with a payout ratio of 10.59%. The company has a consistent dividend policy, providing returns to its shareholders.

Analysts Set New Price Targets

Analysts have recently updated their price targets for Stevanato Group. On June 16, 2026, TD Cowen initiated coverage with a 'buy' rating and a $25 price target. Wolfe Research assumed coverage on June 2, 2026, with a 'buy' rating and a $21 target. The consensus among analysts is a 'buy' recommendation, with an average target price of $24.45 based on 10 analyst opinions.

About Stevanato Group

Stevanato Group S.p.A. designs and produces a range of products and solutions for the healthcare and biopharma industries. Headquartered in Piombino Dese, Italy, the company operates through two segments: Biopharmaceutical and Diagnostic Solutions, and Engineering. It offers drug containment solutions, diagnostic systems, and medical devices, serving clients across the globe. Founded in 1949, Stevanato Group employs over 6,000 people and is led by CEO Franco Stevanato.

Bottom Line

Stevanato Group's recent insider buying and institutional activity reflect ongoing interest in the company. With a solid market position in the healthcare sector, investors keep an eye on its performance. Remember, insider transactions are reported after they occur, and this information is backward-looking.